Načítá se...
A review of the latest research on M(pro) targeting SARS-COV inhibitors
Since the outbreak of COVID-19, the pandemic caused by SARS-CoV-2 infection is still spreading at an alarming rate and has caused huge loss of life and economic damage worldwide. Although more than one year has passed, effective treatments for COVID-19 and other pathogenic coronaviruses have not yet...
Uloženo v:
| Vydáno v: | RSC Med Chem |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
RSC
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292989/ https://ncbi.nlm.nih.gov/pubmed/34355175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d1md00066g |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|